I work as part of the MS research team carrying out commercial and academic studies. I am also involved in the biology of MS and novel imaging techniques.
et al., [(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis., Journal of Nuclear Medicine, ISSN:1535-5667
et al., 2018, Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials., Mult Scler
et al., 2018, Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis, Frontiers in Neurology, Vol:9, ISSN:1664-2295
et al., 2018, Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS, Neurology-neuroimmunology & Neuroinflammation, Vol:5, ISSN:2332-7812
et al., 2018, The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis, Neurology, Vol:90, ISSN:0028-3878, Pages:E2107-E2118